AI-powered medical R&D
Job no longer available
21-100 employees
To tackle inefficiencies in healthcare with disease specific solutions, improving outcomes for patients.
The advancement of AI means that medical data can be analysed to predict health risks, enabling proactive care which reduces costs and improves outcomes. Ikerian, formerly RetinAI Medical, is a Swiss digital healthcare firm dedicated to enabling faster and better healthcare decisions.
The company leverages AI to streamline medical image and data management, standardising and analysing multimodal healthcare data. It serves a range of medical sectors, including rare diseases, and has made noteworthy collaborations with industry leaders and major pharma players. In 2024, it made moves into a new market, debuting the discovery platform for ophthalmologists and optometrists.
The company's impressive Series A fundraise highlights the significance of its AI technology, and will support the accelerated development of its offerings. Ultimately, the company's vision is to democratise accessible healthcare, leveraging data to address systemic and chronic diseases.
Steph
Company Specialist at Welcome to the Jungle
Few candidates hear
back within 2 weeks
Mattenhof, Bern, BE
Carlos Ciller
(CEO)Also works as a Startup Trainer and Coach for Venturelab. Previously worked for the Innovation Forum as Director of Global Business Development.
Also works as Project Lead at The Open Toolkit Library. Prior to this, was a Doctoral Assistant for the ARTORG Center for Biomedical Engineering Research.
Sandro De Zanet
(CSO)Previously worked as a Research Engineer for the Federal Polytechnic School of Lausanne. Was also a Software Engineer for both ELCA Informatique and Eiffel Software.
Share this job
View 3 more jobs at Ikerian